Skip to content

The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese Individuals

The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese Individuals

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05643521
Acronym
FixedCarb
Enrollment
14
Registered
2022-12-08
Start date
2022-12-01
Completion date
2024-11-01
Last updated
2022-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Metabolic Syndrome, NAFLD, Overweight and Obesity

Brief summary

The primary aim of this study is to investigate the acute changes in liver fat content in response to a fixed carbohydrate restriction (i.e. intake of 60g/day or 70g/day for women and men, respectively) in individuals with obesity. This will be performed both as 2 days of very low calorie diet (500 and 600 kcal/day for women and men, respectively) and 2 days of eucaloric low carbohydrate diet.

Interventions

OTHERDietary composition of macronutrients and calories

Carbohydrate restriction

Sponsors

University of Copenhagen Danish Research Centre for Magnetic Resonance
CollaboratorUNKNOWN
Nutrition Exercise and sports Copenhagen University
CollaboratorUNKNOWN
Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Crossover Assignment Randomized diet intervention study in a cross over design

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Men (30-75 years) and postmenopausal women 45-75 years old * Hba1c \<48 mmol/mol without antidiabetic treatment * Obese (BMI 27-40 kg/m2) * Non smokers

Exclusion criteria

* Anemia (hemoglobin \<8 mmol/L for men and \<7 mmol/L for women) * TSH outside reference range * Medication known to influence glucose metabolism or appetite regulation * Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner, pacemaker or other electronic device implanted, implanted metal devices, severe claustrophobia * Food allergies (including lactose and gluten intolerance), vegetarian/vegan diet or following specific dietary plans * Alcohol consumptions \>84/168 g/week (women/men) * Strenuous activity level \> 120 minutes per week * \>5 kg weight loss within the last three months or previous bariatric surgery * High risk of fibrosis of the liver (estimated by FIB4 score \> 3,25)

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome is the 1H-Magnetic Resonance Spectroscopy (MRS) determined liver TG content.After 2 days completion of dietary interventionWe will compare MRS of liver TG after each of the two interventions (2 days of VLCD or 2 days of LC) with MRS liver TG obtained after 2 days of eucaloric conventional diet.

Secondary

MeasureTime frame
Secondary outcomes are fasting and postprandial plasma glucose, insulin, and plasma TG concentrations after 2 days VLCD or LC compared with 2 days of eucaloric conventional diet.After 2 days completion of dietary intervention

Other

MeasureTime frameDescription
Explorative outcomesAfter 2 days completion of dietary interventionExplorative outcomes are the effects of VLCD and LC on subsequent food intake in response to an ad libitum lunch meal.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026